Evidence map›Paper›PMID 12097563›Full record

ArticleJournal of virology2002

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.

Karl Haglund, Ingrid Leiner, Kristen Kerksiek, Linda Buonocore, Eric Pamer, John K Rose

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Polyvalent AIDS vaccines.Current HIV research · 2010
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Karl HaglundDepartment of Pathology, Program in Microbiology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Ingrid Leiner
Kristen Kerksiek
Linda Buonocore
Eric Pamer
John K Rose
Yale University · USCzech Academy of Sciences, Institute of Microbiology · CZ

Funding

TNF Mediated Immune Defense Against Listeria InfectionR01AI042135 · NIAID · YALE UNIVERSITY · PI PAMER, ERIC G. · 1998 to 2019
$7.3M
IMMUNE RESPONSES TO VSV/HIV/SIV HYBRIDS IN MACAQUESR01AI045510 · NIAID · YALE UNIVERSITY · PI ROSE, JOHN K. · 1999 to 2010
$6.4M
Development of VSV/HIV Recombinants as HIV VaccinesR37AI040357 · NIAID · YALE UNIVERSITY · PI ROSE, JOHN K. · 2003 to 2012
$3.1M
Immune Responses to VSV/HIV/SIV Hybrids in MacaquesR56AI045510 · NIAID · YALE UNIVERSITY · PI ROSE, JOHN K. · 2008 to 2011
$938k
DEVELOPMENT OF VSV/HIV RECOMBINANTS AS HIV VACCINESR01AI040357 · NIAID · YALE UNIVERSITY · PI ROSE, JOHN · 1996 to 2002
$701k
NIAID NIH HHS AI40357NIAID NIH HHS AI42135NIAID NIH HHS AI45510NIAID NIH HHS R01 AI040357NIAID NIH HHS R01 AI042135NIAID NIH HHS R01 AI045510NIAID NIH HHS R37 AI040357NIAID NIH HHS R56 AI045510
6 · The paper itself

Abstract

We investigated long-term memory and recall cellular immune responses to human immunodeficiency virus type 1 (HIV-1) Env and Gag proteins elicited by recombinant vesicular stomatitis viruses (VSVs) expressing Env and Gag. More than 7 months after a single vaccination with VSV-Env, approximately 6% of CD8(+) splenocytes stained with major histocompatibility complex class I tetramers containing the Env p18-I10 immunodominant peptide and showed a memory phenotype (CD44(Hi)). The level of tetramer-positive cells in memory was about 14% of the peak primary response. Recall responses elicited in these mice 5 days after boosting with a heterologous recombinant vaccinia virus expressing HIV-1 Env showed that 40 to 45% of CD8(+) splenocytes were tetramer positive and activated (CD62L(Lo)), and these cells produced gamma interferon after stimulation with Env peptide, indicating that they were functional. Five months after the boost, the long-term memory cell population (tetramer positive, CD44(Hi)) constituted 30% of the CD8(+) splenocytes. Recall responses to HIV-1 Gag were examined in mice primed with VSV recombinants expressing HIV-1 Gag protein and boosted with a vaccinia virus recombinant expressing Gag. Using this protocol, we found that approximately 40% of CD8(+) splenocytes were activated (CD62L(Lo)) and specific for a Gag immunodominant peptide (tetramer positive). The high-level Gag recall response elicited by the vaccinia virus-Gag was greater than that obtained by boosting with a VSV-Gag vector with a different VSV glycoprotein. The corresponding levels of CD44(Hi) memory cells were also higher long after boosting with vaccinia virus-Gag than after boosting with a glycoprotein exchange VSV-Gag. Our results show that VSV vectors elicit high-level memory CTL responses and that these can be amplified as much as six- to sevenfold using a heterologous boosting vector.

Indexed as

AIDS VaccinesImmunologic MemoryAnimalsCD8-Positive T-LymphocytesCytotoxicity, ImmunologicGene Products, envGene Products, gagGenetic VectorsImmunization ScheduleImmunization, SecondaryMiceMice, Inbred BALB CVaccinationVaccinia virusVesicular stomatitis Indiana virusAIDS VaccinesGene Products, envGene Products, gag

Identifiers

PMID12097563
PMCPMC136360
OpenAlexW1998179482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.